DARPP-32 and t-DARPP isoform in non-small cell lung cancer (NSCLC): could they drive patients’ clinical management and be a therapeutic target?

Similar Items

• The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?
  od: Lamberti, Giuseppe, i dr.
  Izdano: (2020)
• Clinical implications and future perspectives in testing non-small cell lung cancer (NSCLC) for anaplastic lymphoma kinase (ALK) gene rearrangements
  od: Gelsomino, Francesco, i dr.
  Izdano: (2015)
• ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation
  od: Alam, Sk. Kayum, i dr.
  Izdano: (2020)
• DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration
  od: Alam, Sk. Kayum, i dr.
  Izdano: (2018)
• Notching up a new therapeutic strategy for Non-Small Cell Lung Carcinoma (NSCLC)
  od: Maraver, Antonio, i dr.
  Izdano: (2012)